Seewi O, Jaeger C, Bretzel R G, Schönau E
Childrens Hospital of the University of Cologne, Germany.
Exp Clin Endocrinol Diabetes. 2008 May;116(5):293-7. doi: 10.1055/s-2007-1004565.
Type-1 diabetic individuals differ with regard to both, the formation of circulating insulin antibodies, and the incidence of severe hypoglycaemia.
To assess the association of insulin binding to antibodies with the incidence of severe hypoglycaemia.
In a cross sectional study, 73 children with type-1 diabetes mellitus (median age 14 years, duration of diabetes 6 years) were investigated, 22 of whom had experienced severe hypoglycaemia during the past 18 months, and 51 had never experienced severe hypoglycaemia. Of the patients with severe hypoglycaemia 16 had experienced severe unexplained hypoglycaemias, and 6 had experienced severe hypoglycaemias which were explicable (by missed meals, unplanned physical exercise etc.). Insulin binding was measured in a blinded central laboratory by radioimmunoassay, and expressed as ratio bound/unbound insulin; a binding >15% was considered relevant insulin binding.
A total of 38 patients displayed relevant insulin binding (17 of whom had experienced severe hypoglycaemia), and 35 patients did not (5 of whom had experienced severe hypoglycaemia; p=0.0055, Fisher's exact test). Patients with relevant insulin binding were younger (12.2 vs 14.5 years, p=0.006) than patients without relevant insulin binding. From the 16 patients with inexplicable severe hypoglycaemia, 15 displayed relevant insulin binding, compared to 2 of the 6 patients with explicable severe hypoglycaemia (p=0.009). The association of any severe hypoglycaemia, and of inexplicable severe hypoglycaemia, with relevant insulin binding was significant (odds ratio 4.8 (95%CI 1.5-15.2), and 22.1(95%CI 2.7-179.6), p<0.006). Patients with/without relevant insulin binding, or with/without severe hypoglycaemia, did not differ significantly regarding sex, duration of diabetes, number of insulin injections per day, HbA1c and C-peptide levels (ANOVA).
Insulin binding to antibodies >15% appears to be a strong risk factor for inexplicable severe hypoglycaemias in type-1 diabetic children.
1型糖尿病患者在循环胰岛素抗体的形成以及严重低血糖的发生率方面存在差异。
评估胰岛素与抗体结合情况和严重低血糖发生率之间的关联。
在一项横断面研究中,对73例1型糖尿病儿童(中位年龄14岁,糖尿病病程6年)进行了调查,其中22例在过去18个月内发生过严重低血糖,51例从未发生过严重低血糖。在发生严重低血糖的患者中,16例经历过严重不明原因低血糖,6例经历过可解释的严重低血糖(因未进食、无计划的体育锻炼等)。胰岛素结合情况在一个盲法中心实验室通过放射免疫测定法进行测量,并以结合/未结合胰岛素的比率表示;结合率>15%被认为是相关的胰岛素结合。
共有38例患者显示出相关的胰岛素结合(其中17例发生过严重低血糖),35例患者未显示(其中5例发生过严重低血糖;p=0.0055,Fisher精确检验)。有相关胰岛素结合的患者比没有相关胰岛素结合的患者更年轻(12.2岁对14.5岁,p=0.006))。在16例不明原因严重低血糖患者中,15例显示出相关的胰岛素结合,相比之下,6例可解释的严重低血糖患者中有2例显示出相关的胰岛素结合(p=0.009)。任何严重低血糖以及不明原因严重低血糖与相关胰岛素结合之间的关联均具有显著性(比值比分别为4.8(95%CI 1.5 - 15.2)和22.1(95%CI 2.7 - 179.6),p<0.006)。有/无相关胰岛素结合或有/无严重低血糖的患者在性别、糖尿病病程、每日胰岛素注射次数、糖化血红蛋白和C肽水平方面无显著差异(方差分析)。
胰岛素与抗体结合率>15%似乎是1型糖尿病儿童发生不明原因严重低血糖的一个重要危险因素。